Bio.com News & Updates
newsletter at bio.com
Thu Jan 3 19:53:02 EST 2002
Bio.com News & Updates
January 4, 2001
Life On The Net!
1. Science News: "Study Suggests New Treatment for Type I Diabetes"
2. InFocus: "DNA Microarrays: Platforms and Applications"
3. Introducing Content Partner, BIOTECH magazine
4. Investment Research: Introducing Btech Investor
5. Career Center: Set up your free personal profile today
6. Jobs of the Week: "Research Associate, Bioassay" and others
7. Product Spotlight: Amersham's IN Cell Analyzer
1. SCIENCE NEWS
"Knock-out" Pig Is Cloned
Columbia, MO, January 3, 2002-Researchers from the University of
Missouri-Columbia and Immerge BioTherapeutics Inc. have reported they
have successfully cloned the world's first miniature swine with a
specific gene "knocked out" of their DNA. This particular knockout moves
scientists closer to making animal-to-human organ transplantation a
reality, offering additional hope to the more than 75,000 Americans
currently awaiting organs, 16 of whom die each day while waiting.
Turning Up the Heat on Liars
ROCHESTER, MINN.-A study that appears in the January 3, 2002 edition
of Nature has found that a new high-definition technology that involves
measurement of the heat patterns created by the face accurately
detected lying in more than 80 percent of cases studied. The new high
definition technology involves the measurement of the heat patterns
created by the face; these heat patterns change dramatically with lying.
Nanotube 'Peapods' Created
First came fullerenes, those cage-like molecules of 60 carbon atoms
bound in a ball. Then came long, thin soda straws of carbon atoms
called nanotubes. Now there are fullerenes nested within nanotubes,
like so many peas in a pod.
Study Suggests New Treatment for Type I Diabetes
New York, NY (January 2, 2002)-An article just published in the Journal
of Clinical Investigation sets out the results of an investigation into
the immune defects of some 60 persons with immune-mediated diabetes,
the most common form of type 1 diabetes. The study delineates precisely
what predisposes a person to this condition, and the latest, best
measures for diagnosis, prediction, and therapy. Above all, the authors
suggest a new strategy for combatting the disease: stimulate rather than
suppress the patient's immune system.
To view all news, visit http://bio.com/news/research/
To view Industry news, visit http://bio.com/news/pr/
2. INFOCUS WEBCAST
Bio.com's InFocus Webcast, "DNA Microarrays: Platforms and
Applications," was broadcast Wednesday, December 12, 2001.
To listen to the recorded webcast, go to:
To register to win a free T-shirt from either QIAGEN or IDT,
** To read the pdf transcript of our recent webcast,
"Cell-Based Assays in Drug Discovery & Development," go to:
** For complete instructions on how to tune in to Bio.com's
live webcasts, go to:
3. INTRODUCING BIOTECH MAGAZINE
Bio.com is pleased to introduce a new content partner, BIOTECH magazine,
published by The Biotechnology Network.
For enquiries about subscription to the print journal, please call
1-800-305-6686, and be sure to mention bio.com.
Check out these recent articles:
Attracting Venture Capital: A Focused Business Plan
You're working hard exploring the depths of science with a view to
developing new platform technologies, ones that will have broad
application. But how do you make the leap to commercialization? What
is the key difference between a successful business plan-one that wins
funding-and the unsuccessful plan-one that fails to persuade a venture
capital firm? In most business plans that Foragen reviews, the common
failing is their lack of focus.
Contract Manufacturing: Specialization for a Demanding Market
Selecting the optimal contract manufacturer for a new biotechnology
product is a crucial step along the pathway from research to
commercialization. There are many "intangibles" in the selection
process that only the key decision makers in biotech companies can
assess-the more tangible considerations relating to specific facilities
and areas of expertise are the focus of this article.
A Biosecure Growth Chamber
SubTerra is an emerging biotechnology company in White Pine, Michigan,
Which was founded in January of 2000. The remodeled White Pine mine is
now the site of a sophisticated growth chamber. The company targets
biopharmaceutical markets, which require the ability to produce large
quantities of pharmaceutically active plant material at an accelerated
4. INVESTMENT RESEARCH
Bio.com is pleased to welcome Btech Investor and SCO Financial Group
as bio.com content partners.
Btech Investor provides consulting on the biotechnology industry to
the financial and biotechnology communities and publishes the Btech
Investor Reports and Btech Investor News.
For an example of Btech Investor's reports on the biotech industry,
To purchase a subscription to Btech investor, or to browse and/or
purchase individual reports, visit the bio.com store:
SCO Financial Group, a registered investment advisor focused on
identifying emerging growth companies in the healthcare sectors,
has made its investment research available, for free, to online
investors at Bio.com.
For an example, read their latest report on Cytogen, Inc:
For more investment research from SCO Financial Group, go to:
5. CAREER CENTER
Bio.com offers the most comprehensive online Career Center in the life
Set up your free personal profile today at:
Browse all job postings:
6. JOBS OF THE WEEK
Look at what's new on Bio.com Career Center this week:
1. Lockeed Martin Management and Data Systems: Biotechnology Scientist
2. Itrac, LLC: Software Engineer - Informatics
3. R&D Systems: Research Associate, Bioassay
4. Pharmaceuticals Company: Research Associate, Organic Synthesis
5. Biotechnology Company: Pharmacologist
6. Genomics-Based Biopharmaceutical Company: Director of
Browse all jobs at http://career.bio.com/job_search/job_s.cfm
7. PRODUCT HIGHLIGHT
The IN Cell Analyzer from Amersham Biosciences
Amersham's IN Cell Analyzer is a confocal imaging system that makes it
possible to analyze both live and fixed cells very rapidly and at high
resolution to obtain information-rich subcellular data.
For more info on the IN Cell Analyzer, visit
This message is sent to arrays at net.bio.net per your request
To unsubscribe, simply hit Reply from this email account arrays at net.bio.net
and put the word "unsubscribe" in the subject field.
Copyright © 2001, Bio Online. All rights reserved.
More information about the Arrays